preeclampsia; hypertension; predictive index; thrombophilia; prenatal care
Abstract :
[en] Objective
To derive a prediction index based on the most salient history, laboratory and clinical parameters for identifying women at high risk of developing preeclampsia (PE) and to suggest a primary prevention.
Material and method
Non-pregnant women with a history of PE (n =101) were compared to non-pregnant parous women with a history of one or more successful normotensive pregnancies (n =50) but with comparable age, gestation and parity profiles. The parameters included history and clinical examination; laboratory studies (hemostasis, coagulation, vitamins); and morphological and functional tests (cardiovascular and renal functions). Stepwise logistic regression analysis was applied to develop a three step PE prediction index based on the most discriminant parameters. Strategies to prevent PE in the high-risk group are described.
Results
Identification of women at high risk of PE can be done efficiently (88% sensitivity and specificity) using a predictive index based on a simple history, laboratory, clinical and functional information.
Stategies to prevent PE in our high-risk group have given encouraging results during next pregnancy.
Conclusion
Our study gives a predictive index of PE outside of pregnancy and possibilities to do a primary prevention.
Emonts, Patrick ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Seaksan, Sontera; Université de Liège - ULiège > CHR Citadelle
Seidel, Laurence ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique
Thoumsin, Henri; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique CHR
Brichant, Jean-François ; Université de Liège - ULiège > Département des sciences cliniques > Anesthésie et réanimation
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique - Département de mathématique
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Language :
French
Title :
Détermination d'un index prédictif de la preeclampsie en préconceptionnel et propositions thérapeutiques de prévention primaire
Alternative titles :
[en] A predictive index to preeclampsia before pregnancy and a primary prevention
Publication date :
2008
Journal title :
Journal de Gynécologie, Obstétrique et Biologie de la Reproduction
Royal College of Obstetricians and Gynaecologists Press, 2001. Confidential enquiries into maternal deaths. Why mothers die 1997-1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom, London 2001.
Maternal and child health research consortium. Confidential enquiry into stillbirths and deaths in infancy. 8th annual report, London 2001.
Sibai B.M., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
Beaufils M. HTA gravidique et angiogenèse. HTA-info 21 (2006) 12
Tsatsaris V., Goffin F., and Munaut C. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88 (2003) 5555-5563
Audibert Fr. Screening for pre-eclampsia: the quest for the Holy Grail?. Lancet 365 (2005) 1367-1379
Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565-571
Conde-Agudelo A., Villar J., and Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. J Obstet Gynecol 104 (2004) 1367-1391
Tjoa M.L., Oudejans C.B.M., Van Vugt J.M.G., Blankenstein M.A., and Van Wijk I.J. Markers for presymptomatic prediction of pre-eclampsia and intrauterine growth restriction. Hypertens Pregnancy 23 (2004) 171-189
Sibai B.M., Mercer B., and Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 165 (1991) 1408-1412
Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142 (1982) 159-167
Gates S. Thromboembolic disease in pregnancy. Curr Opin Obstet Gynecol 12 (2000) 117-122
Alfirevic Z., Roberts D., and Martlew V. How strong is the association between maternal thrombophilia and adverse adverse pregnancy outcome? Asystematic review. Eur J Obstet Gynecol Reprod Biol 101 (2002) 6-14
Empson M., Lassere M., Craig J.C., and Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99 (2002) 135-144
Ghee C.B., and Burrows R.F. Prothrombin G20210A mutation is not associated with recurrent miscarriages. Aust N Z J Obstet Gynecol 42 (2002) 167-169
Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87 (2002) 779-785
Greer I.A. Thrombophilia: implications for pregnancy outcome. Thromb Res 2152 (2003) 1-9
Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
Lin J., and August P. Genetic Thrombophilias and pre-eclampsia: a meta-analysis. Obstet Gynecol 105 (2005) 182-192
Robertson L., Wu O., Langhorne P., Twaddle S., Clark P., Lowe G.D., et al. Thrombophilia in pregnancy: a systematic review. Br J Haemat 132 (2006) 171-186
Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe preeclampsia. Presented at the 21st Annual Meeting of the Society of Maternal-Fetal Medicine, 2001, held in Reno, Nevada.
Sibai B.M. Hypertensive Disorders in Women (2001), Sanders chap. 6, p104
Chesley L.C. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 112 (1972) 440-450
Silver H.M., Seebeck M.A., and Carlson R. Comparison of total blood volume in normal, pre-eclamptic, and non proteinuric gestational hypertensive pregnancy by subcutaneous measurement of red blood cell and plasma volume. Am J Obstet Gynecol 179 (1998) 87-93